FindTrial
Sign In

Lucentis®

DRUG5 trials

Sponsors

Retinal Consultants of Arizona, AO GENERIUM, Chong Kun Dang Pharmaceutical, Shanghai Biomabs Pharmaceutical Co., Ltd., Laboratorios Sophia S.A de C.V.

Conditions

Age Related Macular Degeneration (ARMD)Diabetic Macular EdemaNeovascular Age-Related Macular DegenerationNeovascular(Wet) Age Related Macular DegenerationWet Age-related Macular Degeneration

Phase 1

An Open-Label Investigator Sponsored Trial to Investigate the Safety, Tolerability and Development of Subfoveal Fibrosis By Intravitreal Administration of Altering Regimens of Fovista and Anti-VEGF Therapy in Subjects With Neovascular Age-Related Macular Degeneration
CompletedNCT02591914
Retinal Consultants of ArizonaNeovascular Age-Related Macular Degeneration
Start: 2014-02-28End: 2016-05-24Updated: 2018-09-24
Phase I Study to Compare CMAB818 Injection and Lucentis® in Patients With Wet AMD
CompletedNCT04884399
Shanghai Biomabs Pharmaceutical Co., Ltd.Wet Age-related Macular Degeneration
Start: 2021-06-03End: 2022-12-22Updated: 2024-03-28

Phase 3

Efficacy, Safety, pharmacokinetiсs, Immunogenicity of GNR-067 and Lucentis®
NCT04667039
AO GENERIUMAge Related Macular Degeneration (ARMD)
Start: 2022-03-20End: 2024-09-15Target: 408Updated: 2023-09-13
A Study To Evaluate CKD-701 and Lucentis® in Patients With Neovascular(Wet) Age Related Macular Degeneration
CompletedNCT04857177
Chong Kun Dang PharmaceuticalNeovascular(Wet) Age Related Macular Degeneration
Start: 2018-10-19End: 2021-03-17Updated: 2021-04-23
Clinical Study to Evaluate PRO-169 for Diabetic Macular Edema
CompletedNCT05217680
Laboratorios Sophia S.A de C.V.Diabetic Macular Edema
Start: 2021-05-24End: 2025-11-25Updated: 2026-05-26

Related Papers

One-year results of visual response following intravitreal novel anti-VEGF injection for diabetic macular edema in a Latino population.
2025-08-01
Evaluation of the Relationship Between Diabetic Macular Edema and Renal Function in a Latino Population.
2023-08-061 citations